US equities |
GOOGL $283.82 ▼-12.64% GOOG $282.32 ▼-12.29% MU $934.27 ▼-4.98% MSFT $530.14 ▼-0.16% AMZN $243.79 ▼-4.25% META $624.52 ▲+1.96% NVDA $213.66 ▼-0.80% AAPL $348.91 ▲+1.48%
FinancialContent

Heartbeam, Inc. - Common Stock (NQ:BEAT)

0.5389 +0.0071 (+1.34%)
Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Heartbeam, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Present Heart Attack Detection Pilot Study Results at TCT 2026
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026
From HeartBeam, Inc.
Via Business Wire
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Gains FDA Acceptance Into TAP Pilot Program for 3D ECG Technology
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP)
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in 486-Patient Heart Attack Detection Study
Via Investor Brand Network
Topics Intellectual Property
News headline image
HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
From HeartBeam, Inc.
Via Business Wire
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Joins European Cardiovascular Research Consortium to Lead HEART-CHECK Study
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
From HeartBeam, Inc.
Via Business Wire
News headline image
3 Stocks BEAT, MOBX, PRSO Now: FDA Breakthrough, Rare Earths and Military Drones Drive Catalysts
Via AB Newswire
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Receives FDA Breakthrough Device Designation for At-Home Heart Attack Assessment
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
From HeartBeam, Inc.
Via Business Wire
News headline image
HeartBeam, Inc. Letter to Shareholders
From HeartBeam, Inc.
Via Business Wire
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Heart Attack Detection Program, Extends Cash Runway Into 2027
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Reports Second Quarter 2026 Results
From HeartBeam, Inc.
Via Business Wire
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Sets Aug. 13 Call To Review Q2 Results and Strategy
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Patent Expands Cardiac Monitoring Platform With Heart Failure and Structural Heart Disease Capabilities
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
From HeartBeam, Inc.
Via Business Wire
News headline image
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
Via Investor Brand Network
Topics Intellectual Property
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategy
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection
Via Investor Brand Network
Topics Death
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Reports First Quarter 2026 Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients
Via Investor Brand Network
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >